L.A. billionaire founds new 'omics company

01/30/2013 | Bloomberg · Bloomberg Television

Dr. Patrick Soon-Shiong, who founded two drug companies, including Abraxis BioScience, has started a new company named NantOmics to change the way cancer is treated. The company aims to create a convergence of genomics technology and social networks to amass and manage data that leads to personalized treatment with kinase inhibitors. Under the NantOmics model, cancer will be treated based not on where it is in the body but on its genetic composition.

View Full Article in:

Bloomberg · Bloomberg Television

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX